Synthesis and evaluation of 4-triazolylflavans as new aromatase inhibitors

Bioorganic and Medicinal Chemistry Letters

Volumn 14, Issue 20, 2004, Pages 5215-5218

  Yahiaoui, Samir ^a   Pouget, Christelle ^a   Fagnere, Catherine ^a   Champavier, Yves ^b   Habrioux, Gérard ^a   José Chulia, Albert ^a  

^a UPRES EA 1085 'Biomolecules C   (France)

^b UNIVERSITY OF LIMOGES   (France)

Author keywords

4 Triazolylflavans; Aromatase inhibition; Breast cancer

Indexed keywords

2,4 (7 HYDROXY) 4 1H 1,2,4 TRIAZOL 1 YLFLAVAN; 2,4 (7 HYDROXY) 4 4H 1,2,4 TRIAZOL 4 YLFLAVAN; 2,4 (7 METHOXY) 4 1H 1,2,4 TRIAZOL 1 YLFLAVAN; 2,4 (7 METHOXY) 4 4H 1,2,4 TRIAZOL 4 YLFLAVAN; ANASTROZOLE; AROMATASE; AROMATASE INHIBITOR; FLAVAN DERIVATIVE; LETROZOLE; UNCLASSIFIED DRUG;

ARTICLE; BREAST TUMOR; DRUG ACTIVITY; DRUG SYNTHESIS; ENZYME INHIBITION;

ANTINEOPLASTIC AGENTS; AROMATASE INHIBITORS; FLAVONES; HUMANS; MICROSOMES; PLACENTA; STRUCTURE-ACTIVITY RELATIONSHIP; TRIAZOLES;

EID: 4544306064     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2004.07.090     Document Type: Article

References (18)

1. H.V. Bossche J. Steroid Biochem. Mol. Biol. 43 1992 1003
2. A.M.H. Brodie, and V.C.O. Njar Steroids 65 2000 171
3. P.E. Goss, and K. Strasser J. Clin. Oncol. 19 2001 881
4. C.D. Jones, M.A. Winter, K.S. Hirsch, N. Stamm, H.M. Taylor, H.E. Holden, J.D. Davenport, E.V. Krumkalns, and R.G. Suhr J. Med. Chem. 33 1990 416
5. M. Okada, T. Yoden, E. Kawaminami, Y. Shimada, M. Kudoh, Y. Isomura, H. Shikama, and T. Fujikura Chem. Pharm. Bull. 44 1996 1871
6. M. Okada, T. Yoden, E. Kawaminami, Y. Shimada, M. Kudoh, and Y. Isomura Chem. Pharm. Bull. 45 1997 333
7. C. Pouget, C. Fagnere, J.P. Basly, G. Habrioux, and A.J. Chulia Bioorg. Med. Chem. Lett. 12 2002 2859
8. J.C. Le Bail, T. Laroche, F. Marre-Fournier, and G. Habrioux Cancer Lett. 133 1998 101
9. H.J. Jeong, Y.G. Shin, I.H. Kim, and J.M. Pezzuto Arch. Pharm. Res. 22 1999 309
10. D. Ibarreta, A. Daxenberger, and H.H.D. Meyer APMIS 109 2001 161
11. S. Mäkelä, M.J. Poutanen, M.L. Kostian, N. Lehtimäki, L. Strauss, R. Santti, and R. Vinhko PSEBM 217 1998 310
12. C. Pouget, C. Fagnere, J.P. Basly, H. Leveque, and A.J. Chulia Tetrahedron 56 2000 6047
13. T.W. Bentley, L.M. Howle, and P.J. Wareham Tetrahedron 48 1992 7869
14. P. Marchand, M. Le Borgne, M. Duflos, S. Robert-Piessard, G. Le Baut, M. Ahmadi, R.W. Hartmann, and M. Palzer Pharm. Pharmacol. Commun. 4 1998 211
15. T.K. Vinh, S.W. Yee, A.J. Kirby, P.J. Nicholls, and C. Simons Anticancer Drug Des. 16 2002 217
16. T.K. Vinh, M. Ahmadi, P.O. Lopez Delgado, S. Fernandez Perez, H.M. Walters, H.J. Smith, P.J. Nicholls, and C. Simons Bioorg. Med. Chem. Lett. 9 1999 2105
17. M. Lang, C. Batzl, P. Furet, R. Bowman, A. Häusher, and A.S. Bhatnagar J. Steroid Biochem. Mol. Biol. 44 1993 421
18. H.J. Smith, P.J. Nicholls, C. Simons, and R. Le Lain Exp. Opin. Ther. Patents 11 2001 789